Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


MCNULTY JAMES A Create: Alert

All | News | Filings
Date FiledTypeDescription
05/17/2023 4 MCNULTY JAMES A (See Remarks) has filed a Form 4 on Inhibitor Therapeutics, Inc.
Txns: Disposed of 79,627,069 shares @ $0
Acquired 398,135 shares @ $0
Acquired 20,101,057 shares @ $0
05/17/2023 3 Black Robe Capital LLC (10% Owner) has filed a Form 3 on Inhibitor Therapeutics, Inc.
12/22/2022 3 MCNULTY JAMES A (See Remarks) has filed a Form 3 on Inhibitor Therapeutics, Inc.
06/18/2020 4 MCNULTY JAMES A (Director) has filed a Form 4 on CV Sciences, Inc.
Txns: Granted 230,000 options to buy @ $0.75, valued at $172.5k
06/06/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/26/2017 4 MCNULTY JAMES A (Director) has filed a Form 4 on CV Sciences, Inc.
Txns: Acquired 45,000 shares @ $0.405, valued at $18.2k
Acquired 1,450,500 shares @ $0.413, valued at $599.1k
07/21/2016 4 MCNULTY JAMES A (Director) has filed a Form 4 on CV Sciences, Inc.
04/08/2016 3 MCNULTY JAMES A (Director) has filed a Form 3 on CV Sciences, Inc.
01/28/2014 4 Form 4 - Statement of changes in beneficial ownership of securities
08/19/2013 4 MCNULTY JAMES A (CFO) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC
Txns: Bought 5,000 shares @ $4.5, valued at $22.5k
09/27/2012 4 Form 4 - Statement of changes in beneficial ownership of securities
07/10/2012 4 MCNULTY JAMES A (CFO) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC
Txns: Sold 34,109 shares @ $5, valued at $170.5k
Sold 32,408 shares @ $5, valued at $162k
Sold 26,189 shares @ $5, valued at $130.9k
Sold 10,000 shares @ $5, valued at $50k
Sold 6,092 shares @ $5, valued at $30.5k
Exercised 34,109 options @ $2.42, valued at $82.5k
Exercised 32,408 options @ $2.85, valued at $92.4k
Exercised 26,189 options @ $2.94, valued at $77k
Exercised 10,000 options @ $3.03, valued at $30.3k
Exercised 6,092 options @ $2.01, valued at $12.2k
07/05/2012 4 MCNULTY JAMES A (CFO) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC
Txns: Sold 2,323 shares @ $4.5, valued at $10.5k
Sold 3,769 shares @ $4.5, valued at $17k
Sold 6,667 shares @ $4.5, valued at $30k
Sold 12,479 shares @ $4.62, valued at $57.7k
Exercised 2,323 options @ $2.01, valued at $4.7k
Exercised 6,667 options @ $1.96, valued at $13.1k
Exercised 3,769 options @ $2.01, valued at $7.6k
Exercised 12,479 options @ $1.96, valued at $24.5k
05/10/2012 4 MCNULTY JAMES A (CFO) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC
Txns: Sold 21,696 shares @ $4, valued at $86.8k
Exercised 6,093 options @ $2.01, valued at $12.2k
Exercised 15,603 options @ $2.05, valued at $32k
03/13/2012 4 MCNULTY JAMES A (CFO) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC
Txns: Granted 51,020 options @ $1.78, valued at $90.8k
Granted 19,156 options @ $1.96, valued at $37.5k
03/17/2011 4 Form 4 - Statement of changes in beneficial ownership of securities
01/31/2011 5 Form 5 - Annual statement of changes in beneficial ownership of securities
07/23/2010 4 Form 4 - Statement of changes in beneficial ownership of securities
07/23/2010 4 MCNULTY JAMES A (CFO) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC
Txns: Granted 24,844 options @ $2.43, valued at $60.4k
03/25/2010 4 MCNULTY JAMES A (CFO) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC
Txns: Bought 1,500 shares @ $4.03, valued at $6k
06/09/2009 4 MCNULTY JAMES A (CFO) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC
06/05/2009 4 MCNULTY JAMES A (CFO) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC
05/21/2009 4 MCNULTY JAMES A (CFO) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC
02/14/2008 5 Form 5 -- Annual statement of changes in beneficial ownership of securities
02/14/2007 5 MCNULTY JAMES A (CFO) has filed a Form 5 on BIODELIVERY SCIENCES INTERNATIONAL INC
02/14/2006 5 MCNULTY JAMES A (CFO) has filed a Form 5 on BIODELIVERY SCIENCES INTERNATIONAL INC

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy